HEADER GENE REGULATION 15-JUL-20 6ZS3 TITLE CRYSTAL STRUCTURE OF THE FIFTH BROMODOMAIN OF HUMAN PROTEIN POLYBROMO- TITLE 2 1 IN COMPLEX WITH 2-(6-AMINO-5-(PIPERAZIN-1-YL)PYRIDAZIN-3-YL)PHENOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN POLYBROMO-1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HPB1,BRG1-ASSOCIATED FACTOR 180,BAF180,POLYBROMO-1D; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PBRM1, BAF180, PB1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BROMODOMAIN, COMPLEX, SMALL MOLECULE, STRUCTURAL GENOMICS CONSORTIUM, KEYWDS 2 SGC, TRANSCRIPTION, GENE REGULATION EXPDTA X-RAY DIFFRACTION AUTHOR F.PREUSS,A.C.JOERGER,M.WANIOR,A.KRAEMER,S.KNAPP,STRUCTURAL GENOMICS AUTHOR 2 CONSORTIUM (SGC) REVDAT 3 31-JAN-24 6ZS3 1 REMARK REVDAT 2 05-MAY-21 6ZS3 1 JRNL REVDAT 1 07-OCT-20 6ZS3 0 JRNL AUTH M.WANIOR,F.PREUSS,X.NI,A.KRAMER,S.MATHEA,T.GOBEL, JRNL AUTH 2 D.HEIDENREICH,S.SIMONYI,A.S.KAHNT,A.C.JOERGER,S.KNAPP JRNL TITL PAN-SMARCA/PB1 BROMODOMAIN INHIBITORS AND THEIR ROLE IN JRNL TITL 2 REGULATING ADIPOGENESIS. JRNL REF J.MED.CHEM. V. 63 14680 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 33216538 JRNL DOI 10.1021/ACS.JMEDCHEM.0C01242 REMARK 2 REMARK 2 RESOLUTION. 1.67 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.67 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 53.60 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.338 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 35714 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.065 REMARK 3 FREE R VALUE TEST SET COUNT : 1809 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 53.6000 - 3.9146 1.00 2735 149 0.1957 0.2235 REMARK 3 2 3.9146 - 3.1072 1.00 2669 128 0.2003 0.2322 REMARK 3 3 3.1072 - 2.7145 1.00 2643 135 0.2244 0.2311 REMARK 3 4 2.7145 - 2.4663 0.99 2603 152 0.2190 0.2590 REMARK 3 5 2.4663 - 2.2895 0.97 2559 125 0.2189 0.2458 REMARK 3 6 2.2895 - 2.1545 0.99 2565 155 0.2035 0.2394 REMARK 3 7 2.1545 - 2.0466 0.99 2590 144 0.2100 0.2683 REMARK 3 8 2.0466 - 1.9575 0.99 2572 151 0.2214 0.2503 REMARK 3 9 1.9575 - 1.8822 0.99 2594 147 0.2212 0.2679 REMARK 3 10 1.8822 - 1.8172 0.99 2590 131 0.2266 0.2663 REMARK 3 11 1.8172 - 1.7604 0.99 2609 127 0.2211 0.2477 REMARK 3 12 1.7604 - 1.7101 0.99 2599 126 0.2295 0.2476 REMARK 3 13 1.7101 - 1.6700 0.99 2577 139 0.2335 0.3006 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.174 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.702 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.81 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 1921 REMARK 3 ANGLE : 0.805 2589 REMARK 3 CHIRALITY : 0.046 276 REMARK 3 PLANARITY : 0.005 359 REMARK 3 DIHEDRAL : 13.976 1223 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6ZS3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-JUL-20. REMARK 100 THE DEPOSITION ID IS D_1292108286. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-MAY-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91842 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35732 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.670 REMARK 200 RESOLUTION RANGE LOW (A) : 53.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.09700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.67 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.29000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5FH7 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22% (W/V) PEG 3350, 0.2 M SODIUM REMARK 280 MALONATE, 10% (V/V) ETHYLENE GLYCOL, 0.1 M BIS-TRIS PROPANE PH REMARK 280 7.1, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z+1/2 REMARK 290 4555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 20.68832 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 20.59500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 66.54312 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 20.68832 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 20.59500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 66.54312 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 643 REMARK 465 MET A 644 REMARK 465 SER A 645 REMARK 465 GLY A 646 REMARK 465 ILE A 647 REMARK 465 SER A 648 REMARK 465 PRO A 649 REMARK 465 LYS A 650 REMARK 465 LYS A 651 REMARK 465 SER A 652 REMARK 465 LYS A 653 REMARK 465 GLU A 764 REMARK 465 GLY A 765 REMARK 465 ASP A 766 REMARK 465 SER B 643 REMARK 465 MET B 644 REMARK 465 SER B 645 REMARK 465 GLY B 646 REMARK 465 ILE B 647 REMARK 465 SER B 648 REMARK 465 PRO B 649 REMARK 465 LYS B 650 REMARK 465 LYS B 651 REMARK 465 SER B 652 REMARK 465 LEU B 763 REMARK 465 GLU B 764 REMARK 465 GLY B 765 REMARK 465 ASP B 766 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 670 CE NZ REMARK 470 LYS A 675 CG CD CE NZ REMARK 470 ARG A 761 CD NE CZ NH1 NH2 REMARK 470 LYS B 653 CG CD CE NZ REMARK 470 LYS B 675 CG CD CE NZ REMARK 470 LYS B 701 CD CE NZ REMARK 470 LYS B 702 CG CD CE NZ REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1018 DISTANCE = 7.70 ANGSTROMS REMARK 525 HOH A1019 DISTANCE = 8.81 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FX5 A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 803 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FX5 B 801 DBREF 6ZS3 A 645 766 UNP Q86U86 PB1_HUMAN 645 766 DBREF 6ZS3 B 645 766 UNP Q86U86 PB1_HUMAN 645 766 SEQADV 6ZS3 SER A 643 UNP Q86U86 EXPRESSION TAG SEQADV 6ZS3 MET A 644 UNP Q86U86 EXPRESSION TAG SEQADV 6ZS3 SER B 643 UNP Q86U86 EXPRESSION TAG SEQADV 6ZS3 MET B 644 UNP Q86U86 EXPRESSION TAG SEQRES 1 A 124 SER MET SER GLY ILE SER PRO LYS LYS SER LYS TYR MET SEQRES 2 A 124 THR PRO MET GLN GLN LYS LEU ASN GLU VAL TYR GLU ALA SEQRES 3 A 124 VAL LYS ASN TYR THR ASP LYS ARG GLY ARG ARG LEU SER SEQRES 4 A 124 ALA ILE PHE LEU ARG LEU PRO SER ARG SER GLU LEU PRO SEQRES 5 A 124 ASP TYR TYR LEU THR ILE LYS LYS PRO MET ASP MET GLU SEQRES 6 A 124 LYS ILE ARG SER HIS MET MET ALA ASN LYS TYR GLN ASP SEQRES 7 A 124 ILE ASP SER MET VAL GLU ASP PHE VAL MET MET PHE ASN SEQRES 8 A 124 ASN ALA CYS THR TYR ASN GLU PRO GLU SER LEU ILE TYR SEQRES 9 A 124 LYS ASP ALA LEU VAL LEU HIS LYS VAL LEU LEU GLU THR SEQRES 10 A 124 ARG ARG ASP LEU GLU GLY ASP SEQRES 1 B 124 SER MET SER GLY ILE SER PRO LYS LYS SER LYS TYR MET SEQRES 2 B 124 THR PRO MET GLN GLN LYS LEU ASN GLU VAL TYR GLU ALA SEQRES 3 B 124 VAL LYS ASN TYR THR ASP LYS ARG GLY ARG ARG LEU SER SEQRES 4 B 124 ALA ILE PHE LEU ARG LEU PRO SER ARG SER GLU LEU PRO SEQRES 5 B 124 ASP TYR TYR LEU THR ILE LYS LYS PRO MET ASP MET GLU SEQRES 6 B 124 LYS ILE ARG SER HIS MET MET ALA ASN LYS TYR GLN ASP SEQRES 7 B 124 ILE ASP SER MET VAL GLU ASP PHE VAL MET MET PHE ASN SEQRES 8 B 124 ASN ALA CYS THR TYR ASN GLU PRO GLU SER LEU ILE TYR SEQRES 9 B 124 LYS ASP ALA LEU VAL LEU HIS LYS VAL LEU LEU GLU THR SEQRES 10 B 124 ARG ARG ASP LEU GLU GLY ASP HET FX5 A 801 20 HET EDO A 802 4 HET EDO A 803 4 HET FX5 B 801 20 HETNAM FX5 2-(6-AZANYL-5-PIPERAZIN-4-IUM-1-YL-PYRIDAZIN-3-YL) HETNAM 2 FX5 PHENOL HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 FX5 2(C14 H18 N5 O 1+) FORMUL 4 EDO 2(C2 H6 O2) FORMUL 7 HOH *223(H2 O) HELIX 1 AA1 THR A 656 TYR A 672 1 17 HELIX 2 AA2 SER A 681 LEU A 685 5 5 HELIX 3 AA3 LEU A 693 ILE A 700 1 8 HELIX 4 AA4 ASP A 705 ALA A 715 1 11 HELIX 5 AA5 ASP A 720 ASN A 739 1 20 HELIX 6 AA6 SER A 743 LEU A 763 1 21 HELIX 7 AA7 THR B 656 TYR B 672 1 17 HELIX 8 AA8 ARG B 679 LEU B 685 5 7 HELIX 9 AA9 LEU B 693 ILE B 700 1 8 HELIX 10 AB1 ASP B 705 ALA B 715 1 11 HELIX 11 AB2 ASP B 720 ASN B 739 1 20 HELIX 12 AB3 SER B 743 ASP B 762 1 20 SITE 1 AC1 13 ILE A 683 PHE A 684 LEU A 687 LEU A 693 SITE 2 AC1 13 TYR A 696 MET A 704 ALA A 735 TYR A 738 SITE 3 AC1 13 ASN A 739 ILE A 745 HOH A 901 HOH A 976 SITE 4 AC1 13 HOH B 935 SITE 1 AC2 8 ARG A 690 TYR A 697 PHE A 732 ASN A 733 SITE 2 AC2 8 CYS A 736 LEU A 750 HIS A 753 HOH A 908 SITE 1 AC3 7 ALA A 682 ILE A 683 LEU A 685 ARG A 686 SITE 2 AC3 7 HOH A 970 ILE B 745 HOH B 917 SITE 1 AC4 10 HOH A 917 ILE B 683 PHE B 684 LEU B 687 SITE 2 AC4 10 TYR B 696 MET B 704 ALA B 735 TYR B 738 SITE 3 AC4 10 ASN B 739 ILE B 745 CRYST1 56.180 41.190 133.907 90.00 96.35 90.00 I 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017800 0.000000 0.001980 0.00000 SCALE2 0.000000 0.024278 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007514 0.00000